Requip XL (Ropinirole)

Requip XL (Ropinirole) Medication Information

Uses

Requip is a dopamine agonist that is used to treat Parkinson’s disease. 

Dosage

The tablets are available in several different strengths:

• 2 mg
• 4 mg
• 6 mg
• 8 mg
• 12 mg

Side Effects

The most common side effects of Requip include:

• Nausea
• Somnolence
• Hypertension 
• Headache 
• Abdominal pain
• Dizziness
• Constipation 

Speak with your doctor for a full list of side effects that apply to you if you are taking Requip.

Precautions

Requip can cause drowsiness, and sudden sleepiness, which can be dangerous if patients are operating heavy machinery. 

Requip can cause a change in blood pressure and heart rate, so it is important to monitor these in patients. 

This medication can cause problems with impulse control and make patients more compulsive. 

Interactions

The most common drug interactions with Requip include:

• Estrogen
• Phenothiazines
• Butyrophenones
• Thioxanthenes
• Metoclopramide

Speak with your doctor for more information and before starting a new medication with Requip. 

Storage

Store at room temperature (77ºF). Requip should be dispensed in a tight and light-resistant container. 

Pharmacist Tips

• Requip needs to be taken as it is prescribed by your doctor. 
• Requip can be taken with or without food, but it needs to be swallowed whole. 
• Requip contains ropinirole, this medication is also available as an immediate release tablet.  

Ropinirole FAQs

Can Requip keep you awake?

Requip usually makes patients drowsy. 

How long does Requip last?

Requip can stay in the body up to 30 hours. 

Can you stop Requip abruptly?

Patients can experience withdrawal if they stop this medication quickly. 

Is Requip a muscle relaxant?

No, Requip is not a muscle relaxant, it work on the dopamine receptor in the brain. 

Does Requip help with anxiety?

Requip has been shown to help with anxiety and depression symptoms. 

Related Drugs

• Azilect
• Exelon
• Mirapex
• Neupro
• Sinemet
• Stalevo
• Tasmar
• Mirapex

Reference:

Requip {package insert}. Research Triangle Park, NC: GlaxoSmithKline; 2017.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022008s009lbl.pdf